Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people.
Smoking, metabolic syndrome (MetS), and major adverse cardiovascular events (MACEs) are important global health problems. We aimed to investigate the association between smoking, alteration in MetS status, and the consequent risk of MACE. We performed a nationwide observational cohort study based on...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2021-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0241623 |
| _version_ | 1819141214474076160 |
|---|---|
| author | Sehoon Park Kyungdo Han Soojin Lee Yaerim Kim Yeonhee Lee Min Woo Kang Sanghyun Park Yong Chul Kim Seung Seok Han Hajeong Lee Jung Pyo Lee Kwon Wook Joo Chun Soo Lim Yon Su Kim Dong Ki Kim |
| author_facet | Sehoon Park Kyungdo Han Soojin Lee Yaerim Kim Yeonhee Lee Min Woo Kang Sanghyun Park Yong Chul Kim Seung Seok Han Hajeong Lee Jung Pyo Lee Kwon Wook Joo Chun Soo Lim Yon Su Kim Dong Ki Kim |
| author_sort | Sehoon Park |
| collection | DOAJ |
| description | Smoking, metabolic syndrome (MetS), and major adverse cardiovascular events (MACEs) are important global health problems. We aimed to investigate the association between smoking, alteration in MetS status, and the consequent risk of MACE. We performed a nationwide observational cohort study based on the claims database of Korea. We included people with ≥ 3 national health screenings from 2009 to 2013. Total 6,099,717 people, including 3,576,236 nonsmokers, 862,210 ex-smokers, 949,586 light-to-moderate smokers, and 711,685 heavy smokers, at the first health screening, were investigated. First, we performed a logistic regression analysis using smoking status at the first screening as the exposure variable and MetS development or recovery as the outcome variable. Second, we performed a Poisson regression using smoking status at the third screening as the exposure variable and the outcome was risk of incident MACEs. Among those previously free from MetS (N = 4,889,493), 347,678 people developed MetS, and among those who had previous MetS (N = 1,210,224), 347,627 people recovered from MetS. Smoking was related to a higher risk of MetS development [for heavy smokers: adjusted OR 1.71 (1.69 to 1.73)] and a lower probability of MetS recovery [for heavy smokers: adjusted OR 0.68 (0.67 to 0.69)]. Elevated triglycerides was the MetS component with the most prominent association with smoking. The risk for incident MACEs (78,640 events during a median follow-up of 4.28 years) was the highest for heavy smokers, followed in order by light-to-moderate, ex-smokers and nonsmokers, for every MetS status. Therefore, smoking may promote MetS or even hinder recovery from MetS. Smoking cessation should be emphasized to reduce MACE risk even for those without MetS. |
| first_indexed | 2024-12-22T11:50:54Z |
| format | Article |
| id | doaj.art-e55f9fb1098c45f9b6124cc20e038e94 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-22T11:50:54Z |
| publishDate | 2021-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-e55f9fb1098c45f9b6124cc20e038e942022-12-21T18:27:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032021-01-01161e024162310.1371/journal.pone.0241623Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people.Sehoon ParkKyungdo HanSoojin LeeYaerim KimYeonhee LeeMin Woo KangSanghyun ParkYong Chul KimSeung Seok HanHajeong LeeJung Pyo LeeKwon Wook JooChun Soo LimYon Su KimDong Ki KimSmoking, metabolic syndrome (MetS), and major adverse cardiovascular events (MACEs) are important global health problems. We aimed to investigate the association between smoking, alteration in MetS status, and the consequent risk of MACE. We performed a nationwide observational cohort study based on the claims database of Korea. We included people with ≥ 3 national health screenings from 2009 to 2013. Total 6,099,717 people, including 3,576,236 nonsmokers, 862,210 ex-smokers, 949,586 light-to-moderate smokers, and 711,685 heavy smokers, at the first health screening, were investigated. First, we performed a logistic regression analysis using smoking status at the first screening as the exposure variable and MetS development or recovery as the outcome variable. Second, we performed a Poisson regression using smoking status at the third screening as the exposure variable and the outcome was risk of incident MACEs. Among those previously free from MetS (N = 4,889,493), 347,678 people developed MetS, and among those who had previous MetS (N = 1,210,224), 347,627 people recovered from MetS. Smoking was related to a higher risk of MetS development [for heavy smokers: adjusted OR 1.71 (1.69 to 1.73)] and a lower probability of MetS recovery [for heavy smokers: adjusted OR 0.68 (0.67 to 0.69)]. Elevated triglycerides was the MetS component with the most prominent association with smoking. The risk for incident MACEs (78,640 events during a median follow-up of 4.28 years) was the highest for heavy smokers, followed in order by light-to-moderate, ex-smokers and nonsmokers, for every MetS status. Therefore, smoking may promote MetS or even hinder recovery from MetS. Smoking cessation should be emphasized to reduce MACE risk even for those without MetS.https://doi.org/10.1371/journal.pone.0241623 |
| spellingShingle | Sehoon Park Kyungdo Han Soojin Lee Yaerim Kim Yeonhee Lee Min Woo Kang Sanghyun Park Yong Chul Kim Seung Seok Han Hajeong Lee Jung Pyo Lee Kwon Wook Joo Chun Soo Lim Yon Su Kim Dong Ki Kim Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people. PLoS ONE |
| title | Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people. |
| title_full | Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people. |
| title_fullStr | Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people. |
| title_full_unstemmed | Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people. |
| title_short | Smoking, development of or recovery from metabolic syndrome, and major adverse cardiovascular events: A nationwide population-based cohort study including 6 million people. |
| title_sort | smoking development of or recovery from metabolic syndrome and major adverse cardiovascular events a nationwide population based cohort study including 6 million people |
| url | https://doi.org/10.1371/journal.pone.0241623 |
| work_keys_str_mv | AT sehoonpark smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT kyungdohan smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT soojinlee smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT yaerimkim smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT yeonheelee smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT minwookang smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT sanghyunpark smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT yongchulkim smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT seungseokhan smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT hajeonglee smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT jungpyolee smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT kwonwookjoo smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT chunsoolim smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT yonsukim smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople AT dongkikim smokingdevelopmentoforrecoveryfrommetabolicsyndromeandmajoradversecardiovasculareventsanationwidepopulationbasedcohortstudyincluding6millionpeople |